Protein Binding Assays Market To Reach $896.3 Million By 2030

Protein Binding Assays Market Growth & Trends

The global protein binding assays market size is expected to reach USD 896.3 million by 2030 at a CAGR of 10.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Protein binding assays are increasingly being adopted in preclinical stages of drug discovery & development programs. These assays help in detection of target molecules and provide critical information about the properties of therapeutics and biologics.

Increase in number of R&D outsourcing activities by pharmaceutical companies for development of therapeutics is anticipated to increase the adoption of protein binding assays. Presence of several companies that provide these services for molecule investigation and analysis is expected to positively impact the market growth over the forecast period.

These assays provide help understand ADME properties during selection and development of therapeutic candidates. Estimation of safety margins during drug development is an important step that can be carried out by quantification of binding of new chemical entities to a protein.

 Request a free sample copy or view report summary: Protein Binding Assays Market Report

Protein Binding Assays Market Report Highlights

• The services segment dominated with a market share of 44.7% in 2023. Technological advancements, strategic investments, and increasing consumer demand constitute market growth.

• The equilibrium dialysis dominated with a share of 49.7% in 2023. Scientists and researchers prefer this technique due to its low price and high accuracy. 

• The pharmaceuticals and biotechnology segment dominated with a 46.4% market share in 2023. Factors such as a wide and strong distribution network and significant investments in drug discovery boost the segment growth.

• The North America protein binding assays dominated the global market with a share of 40.8% in 2023.

Protein Binding Assays Market Segmentation

Grand View Research has segmented the global protein binding assays market on the basis of technology, products & services, end use, and region:

Protein Binding Assays Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Instruments

• Kits & Reagents

• Services

Protein Binding Assays Products & Services Outlook (Revenue, USD Million, 2018 - 2030)

• Ultracentrifugation

• Equilibrium Dialysis

• Ultrafiltration

• Surface Plasmon Resonance

• Others

Protein Binding Assays End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Contract Research Organizations

• Pharmaceutical & Biotechnology Companies

• Others

Protein Binding Assays Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Spain

  • Italy

  • Denmark

  • Norway

  • Sweden

• Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • Saudi Arabia

  • UAE

  • Kuwait

  • South Africa

List of Key Players of Protein Binding Assays Market

• Thermo Fisher Scientific

• ADMEcell, Inc.

• Beckman Coulter, Inc.

• Sartorius AG

• Bio-Rad Laboratories, Inc.

• Abzena Ltd

• Abcam Limited

• GVK Biosciences Private Limited

• Promega Corporation

• Arryait Corporation

• Charles River Laboratories

• Sovicell

• Eurofins Scientific

• 3B Pharmaceuticals

• Creative Biolabs

• Evotec SE

• BioDuro-Sundia

• Merck KDaA